162 related articles for article (PubMed ID: 21835828)
1. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.
Du X; Wang S; Lu J; Cao Y; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Li J
Jpn J Clin Oncol; 2011 Sep; 41(9):1086-93. PubMed ID: 21835828
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 expression in gallbladder cancer and its prognostic significance.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
Eur Surg Res; 2008; 41(2):245-50. PubMed ID: 18544939
[TBL] [Abstract][Full Text] [Related]
3. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
4. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM
Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas.
Zhang Y; Zhan H; Xu W; Yuan Z; Lu P; Zhan L; Li Q
Pathol Res Pract; 2011 Jan; 207(1):24-9. PubMed ID: 21087829
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.
Fujimoto D; Hirono Y; Goi T; Katayama K; Yamaguchi A
Anticancer Res; 2008; 28(2A):847-54. PubMed ID: 18507028
[TBL] [Abstract][Full Text] [Related]
7. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
Boire A; Covic L; Agarwal A; Jacques S; Sherifi S; Kuliopulos A
Cell; 2005 Feb; 120(3):303-13. PubMed ID: 15707890
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
Yuan Y; Yang ZL; Zou Q; Li JH; Li DQ; Liang LF; Zeng GX; Chen SL
Neoplasma; 2013; 60(6):698-705. PubMed ID: 23906305
[TBL] [Abstract][Full Text] [Related]
9. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
10. Expression of CDC6 and GDF-9 and their clinicopathological significances in benign and malignant lesions of the gallbladder.
Shu GS; Yang LP; Yang ZL; Jiang S
Cancer Biomark; 2012; 11(2-3):107-14. PubMed ID: 23011157
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of Tiam1-Rac1 signaling in primary gallbladder carcinoma.
Du X; Wang S; Lu J; Wang Q; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Wang C
Med Oncol; 2012 Sep; 29(3):1873-8. PubMed ID: 21853342
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of a disintegrin and metalloprotease-9 in hepatocellular carcinoma: implications for tumor progression and prognosis.
Tao K; Qian N; Tang Y; Ti Z; Song W; Cao D; Dou K
Jpn J Clin Oncol; 2010 Jul; 40(7):645-51. PubMed ID: 20388695
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of latent membrane protein-1, matrix metalloproteinase-1 and Ets-1 transcription factor in tunisian nasopharyngeal carcinoma patients.
Ben Nasr H; Chahed K; Remadi S; Zakhama A; Chouchane L
Arch Med Res; 2009 Apr; 40(3):196-203. PubMed ID: 19427971
[TBL] [Abstract][Full Text] [Related]
16. Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.
Wu LC; Chen LT; Tsai YJ; Lin CM; Lin CY; Tian YF; Sheu MJ; Uen YH; Shiue YL; Wang YH; Yang SJ; Wu WR; Li SH; Iwamuro M; Kobayasshi N; Huang HY; Li CF
J Clin Pathol; 2012 Apr; 65(4):309-14. PubMed ID: 22267983
[TBL] [Abstract][Full Text] [Related]
17. Protease-activating-receptor-2 is frequently expressed in papillary adenocarcinoma of the gallbladder.
Shibata K; Yada K; Matsumoto T; Sasaki A; Ohta M; Kitano S
Oncol Rep; 2004 Nov; 12(5):1013-6. PubMed ID: 15492786
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological study of depth of subserosal invasion in patients with pT2 gallbladder carcinoma.
Sasaki R; Uesugi N; Itabashi H; Fujita T; Takeda Y; Hoshikawa K; Takahashi M; Funato O; Nitta H; Sugai T; Kanno S; Saito K
J Surg Oncol; 2005 Nov; 92(2):83-8. PubMed ID: 16231372
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of LAPTM4B-35 closely correlated with clinicopathological features and post-resectional survival of gallbladder carcinoma.
Zhou L; He XD; Chen J; Cui QC; Qu Q; Rui JA; Zhao YP
Eur J Cancer; 2007 Mar; 43(4):809-15. PubMed ID: 17276673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
